Tens of thousands of prostate cancer cases were missed during the disruption of the COVID pandemic.
Those are the findings of a new study published in BJU International last month.
Researchers from the University of Oxford and other U.K. universities analyzed a dataset of 285,160 participants from OpenSAFELY-TPP, a large, nationally representative dataset of routine health care records.
